- Home
- MTVA vs RYDE Comparison
MTVA vs RYDE Comparison
Compare MTVA & RYDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- RYDE
- Stock Information
- Founded
- MTVA 2014
- RYDE 2014
- Country
- MTVA United States
- RYDE Singapore
- Employees
- MTVA N/A
- RYDE N/A
- Industry
- MTVA
- RYDE
- Sector
- MTVA
- RYDE
- Exchange
- MTVA NYSE
- RYDE NYSE
- Market Cap
- MTVA 7.1M
- RYDE 7.0M
- IPO Year
- MTVA N/A
- RYDE 2024
- Fundamental
- Price
- MTVA $0.68
- RYDE $0.22
- Analyst Decision
- MTVA Strong Buy
- RYDE
- Analyst Count
- MTVA 1
- RYDE 0
- Target Price
- MTVA $12.00
- RYDE N/A
- AVG Volume (30 Days)
- MTVA 222.8K
- RYDE 99.3K
- Earning Date
- MTVA 05-14-2025
- RYDE 05-02-2025
- Dividend Yield
- MTVA N/A
- RYDE N/A
- EPS Growth
- MTVA N/A
- RYDE N/A
- EPS
- MTVA N/A
- RYDE N/A
- Revenue
- MTVA N/A
- RYDE $6,557,978.00
- Revenue This Year
- MTVA N/A
- RYDE $21.13
- Revenue Next Year
- MTVA N/A
- RYDE $13.43
- P/E Ratio
- MTVA N/A
- RYDE N/A
- Revenue Growth
- MTVA N/A
- RYDE 3.27
- 52 Week Low
- MTVA $0.71
- RYDE $0.20
- 52 Week High
- MTVA $5.30
- RYDE $22.49
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- RYDE N/A
- Support Level
- MTVA N/A
- RYDE N/A
- Resistance Level
- MTVA N/A
- RYDE N/A
- Average True Range (ATR)
- MTVA 0.00
- RYDE 0.00
- MACD
- MTVA 0.00
- RYDE 0.00
- Stochastic Oscillator
- MTVA 0.00
- RYDE 0.00
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About RYDE RYDE GROUP LTD
Ryde Group Ltd operates a technology platform that provides a range of ride-hailing, carpooling and delivery focused offerings in Singapore. The company operates in twos segments namely Mobility provides on-demand and scheduled carpooling and ride-hailing services, matching riders to its driver partners; and Quick Commerce provides on-demand, scheduled, and multi-stop parcel delivery services.